Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2014

Open Access 01-12-2014 | Study protocol

A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol

Authors: Susan Coote, Stephen Gallagher, Rachel Msetfi, Aidan Larkin, John Newell, Robert W Motl, Sara Hayes

Published in: BMC Neurology | Issue 1/2014

Login to get access

Abstract

Background

Exercise has consistently yielded short-term, positive effects on health outcomes in people with multiple sclerosis (MS). However, these effects have not been maintained in the long-term. Behaviour change interventions aim to promote long-term positive lifestyle change. This study, namely, “Step it Up” will compare the effect of an exercise plus Social Cognitive Theory (SCT)-based behaviour change intervention with an exercise plus control education intervention on walking mobility among people with MS.

Methods/design

People with a diagnosis of MS who walk independently, score of 0–3 on the Patient Determined Disease Steps, who have not experienced an MS relapse or change in their MS medication in the last 12 weeks and who are physically inactive will be randomised to one of two study conditions. The experimental group will undergo a 10-week exercise plus SCT-based behavioural change intervention. The control group will undergo a 10-week exercise plus education intervention to control for contact. Participants will be assessed at weeks 1, 12, 24 and 36. The primary outcome will be walking mobility. Secondary outcomes will include: aerobic capacity, lower extremity muscle strength, participant adherence to the exercise programme, self-report exercise intensity, self-report enjoyment of exercise, exercise self-efficacy, outcome expectations for exercise, goal-setting for exercise, perceived benefits and barriers to exercise, perceptions of social support, physical and psychological impact of MS and fatigue. A qualitative evaluation of Step it Up will be completed among participants post-intervention.

Discussion

This randomised controlled trial will examine the effectiveness of an exercise plus SCT-based behaviour change intervention on walking mobility among people with MS. To this end, Step it Up will serve to inform future directions of research and clinical practice with regard to sustainable exercise interventions for people with MS.
Literature
1.
Snook EM, Motl RW: Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair. 2009, 23: 108-116. 10.1177/1545968308320641.CrossRefPubMed
2.
Coote S, Finlayson M, Sosnoff JJ: Level of mobility limitations and falls status in persons with multiple sclerosis. Arch Phys Med Rehabil. 2014, 95: 862-866. 10.1016/j.apmr.2013.10.018.CrossRefPubMed
3.
4.
Finlayson M: Introduction: occupational therapy practice and research with persons with multiple sclerosis. Occup Ther Health Care. 2004, 17: 1-4.CrossRefPubMed
5.
Heesen C, Böhm J, Reich C, Kasper J, Goebel M, Gold SM: Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable. Mult Scler. 2008, 14: 988-991. 10.1177/1352458508088916.CrossRefPubMed
6.
Kjolhede T, Vissing K, Dalgas U: Multiple sclerosis and progressive resistance training: a systematic review. Mult Scler. 2012, 18: 1215-1228. 10.1177/1352458512437418.CrossRefPubMed
7.
Latimer-Cheung AE, Martin Ginis KA, Hicks AL, Motl RW, Pilutti LA, Duggan M, Wheeler G, Persad R, Smith KM: Development of evidence-informed physical activity guidelines for adults with multiple sclerosis. Arch Phys Med Rehabil. 2013, 94: 1829-1836. 10.1016/j.apmr.2013.05.015.CrossRefPubMed
8.
Motl RW, Gosney JL: Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis. Mult Scler. 2008, 14: 129-135. 10.1177/1352458507080464.CrossRefPubMed
9.
Kuspinar A, Mayo NE: Do generic utility measures capture what is important to the quality of life of people with multiple sclerosis?. Health Qual Life Outcomes. 2013, 11: 71-81. 10.1186/1477-7525-11-71.CrossRefPubMedPubMedCentral
10.
Andreasen AK, Stenager E, Dalgas U: The effect of exercise therapy on fatigue in multiple sclerosis. Mult Scler. 2011, 17: 1041-1054. 10.1177/1352458511401120.CrossRefPubMed
11.
Pilutti LA, Greenlee TA, Motl RW, Nickrent MS, Petruzzello SJ, Stephen J: Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis. Psychosom Med. 2013, 75: 575-580. 10.1097/PSY.0b013e31829b4525.CrossRefPubMed
12.
Pilutti LA, Platta ME, Motl RW, Latimer-Cheung AE: The safety of exercise training in multiple sclerosis: a systematic review. J Neurol Sci. 2014, 343: 3-7. 10.1016/j.jns.2014.05.016.CrossRefPubMed
13.
Sandroff BM, Motl RW, Suh Y: Accelerometer output and its association with energy expenditure in persons with multiple sclerosis. J Rehabil Res Dev. 2012, 49: 467-476. 10.1682/JRRD.2011.03.0063.CrossRefPubMed
14.
Motl RW, McAuley E, Snook EM: Physical activity and multiple sclerosis: a meta-analysis. Mult Scler. 2005, 11: 459-463. 10.1191/1352458505ms1188oa.CrossRefPubMed
15.
Klaren RE, Motl RW, Dlugonski D, Sandroff BM, Pilutti LA: Objectively quantified physical activity in persons with multiple sclerosis. Arch Phys Med Rehabil. 2013, 94: 2342-2348. 10.1016/j.apmr.2013.07.011.CrossRefPubMed
16.
Motl RW, McAuley E, Snook EM, Gliottoni RC: Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support. Psychol Health Med. 2009, 14: 111-124. 10.1080/13548500802241902.CrossRefPubMedPubMedCentral
17.
Slawta JN, McCubbin JA, Wilcox AR, Fox SD, Nalle DJ, Anderson G: Coronary heart disease risk between active and inactive women with multiple sclerosis. Med Sci Sports Exerc. 2002, 34: 905-912. 10.1097/00005768-200206000-00001.CrossRefPubMed
18.
Lalmohamed A, Bazelier MT, Van Staa TP, Uitdehaag BMJ, Leufkens HGM, De Boer A, De Vries F: Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study. Eur J Neurosci. 2012, 19: 1007-1014. 10.1111/j.1468-1331.2012.03668.x.CrossRef
19.
Motl RW, Fernhall B, McAuley E, Cutter G: Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: evidence from a cross-sectional analysis. Neuroepidemiolgy. 2011, 36: 183-191. 10.1159/000327749.CrossRef
20.
Garrett M, Hogan N, Larkin A, Saunders J, Jakeman P, Coote S: Exercise in the community for people with multiple sclerosis–a follow-up of people with minimal gait impairment. Mult Scler. 2013, 19: 790-798. 10.1177/1352458512461390.CrossRefPubMed
21.
Geidl W, Semrau J, Pfeifer K: Health behaviour change theories: contributions to an ICF-based behavioural exercise therapy for individuals with chronic diseases. Disabil and Rehabil 2014, Epub ahead of print.,
22.
McAuley E, Motl RW, Morris KS, Hu L, Doerksen SE, Elavsky S, Konopack JF: Enhancing physical activity adherence and well-being in multiple sclerosis: a randomised controlled trial. Mult Scler. 2007, 13: 652-659. 10.1177/1352458506072188.CrossRefPubMed
23.
Motl RW, Dlugonski D, Wojcicki TR, McAuley E, Mohr DC: Internet intervention for increasing physical activity in persons with multiple sclerosis. Mult Scler. 2011, 17: 116-128. 10.1177/1352458510383148.CrossRefPubMed
24.
Dlugonski D, Motl RW, McAuley E: Increasing physical activity in multiple sclerosis: replicating Internet intervention effects using objective and self-report outcomes. J Rehabil Res Dev. 2011, 48: 1129-1136. 10.1682/JRRD.2010.09.0192.CrossRefPubMed
25.
Motl RW, Dlugonski D: Increasing physical activity in multiple sclerosis using a behavioral intervention. Behav Med. 2011, 37: 125-31. 10.1080/08964289.2011.636769.CrossRefPubMed
26.
Baert I, Freeman J, Smedal T, Dalgas U, Romberg A, Kalron A, Conyers H, Elorriaga I, Gebara B, Gumse J, Heric A, Jensen E, Jones K, Knuts K, Maertens de Noordhout B, Martic A, Normann B, Eijnde BO, Rasova K, Santoyo Medina C, Truyens V, Wens I, Feys P: Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter study. Neurorehabil Neural Repair. 2014, 28: 621-631. 10.1177/1545968314521010.CrossRefPubMed
27.
Tudor-Locke C, Craig CL, Aoyagi Y, Bell RC, Croteau KA, De Bourdeaudhuij I, Ewald B, Gardner AW, Hatano Y, Lutes LD, Matsudo SM, Ramirez-Marrero FA, Rogers LQ, Rowe DA, Schmidt MD, Tully MA, Blair SN: How many steps/day are enough? For older adults and special populations. Int J Behav Nutr Phys Act. 2011, 8: 80-99. 10.1186/1479-5868-8-80.CrossRefPubMedPubMedCentral
28.
Tudor-Locke C, Sisson SB, Collova T, Lee SM, Swan PD: Pedometer-determined step count guidelines for classifying walking intensity in a young ostensibly healthy population. Can J Appl Physiol. 2005, 30: 666-676. 10.1139/h05-147.CrossRefPubMed
29.
Agiovlasitis S, Motl RW: Step-rate thresholds for physical activity intensity in persons with multiple sclerosis. Adapt Phys Act Q. 2014, 31: 4-18. 10.1123/apaq.2013-0008.CrossRef
30.
Paul L, Coote S, Crosbie J, Dixon D, Hale L, Holloway E, McCrone P, Miller L, Saxton J, Sincock C, White L: Core outcome measures for exercise studies in people with multiple sclerosis: recommendations from a multidisciplinary consensus meeting. Mult Scler. 2014, 20: 1641-1650. 10.1177/1352458514526944.CrossRefPubMed
31.
Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T: Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain. 2007, 127: 35-41. 10.1016/j.pain.2006.07.015.CrossRefPubMed
32.
Goldman MD, Motl RW, Rudick RA: Possible clinical outcome measures for clinical trials in patients with multiple sclerosis. Ther Adv Neurol Disord. 2010, 3: 229-239. 10.1177/1756285610374117.CrossRefPubMedPubMedCentral
33.
Fry DK, Pfalzer LA: Reliability of Four Functional Tests and Rating of Perceived Exertion in Persons with Multiple Sclerosis. Physiotherapy Canada. 2006, 58: 212-220. 10.3138/ptc.58.3.212.CrossRef
34.
Nilsagard Y, Lundholm C, Gunnarsson LG, Dcnison E: Clinical relevance using timed walk tests and ‘timed up and go’ testing in persons with multiple sclerosis. Physiother Res Int. 2007, 12: 105-114. 10.1002/pri.358.CrossRefPubMed
35.
Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ: Measuring the impact of MS on walking ability: the 12-Item MS walking scale (MSWS-12). Neurology. 2003, 60: 31-36. 10.1212/WNL.60.1.31.CrossRefPubMed
36.
McGuigan C, Hutchinson M: The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J Neurol Neurosurg Psychiatry. 2004, 75: 266-269.CrossRefPubMedPubMedCentral
37.
Motl RW, McAuley E, Mullen S: Longitudinal measurement invariance of the multiple sclerosis walking scale-12. J Neurol Sci. 2011, 305: 75-79. 10.1016/j.jns.2011.03.008.CrossRefPubMed
38.
Cavanaugh JT, Gappmaier VO, Dibble LE, Gappmaier E: Ambulatory activity in individuals with multiple sclerosis. J Neurol Phys Ther. 2011, 35: 26-33. 10.1097/NPT.0b013e3182097190.CrossRefPubMed
39.
Csuka M, McCarty DJ: Simple method for measurement of lower extremity muscle strength. Am J Med. 1985, 78: 77-81. 10.1016/0002-9343(85)90465-6.CrossRefPubMed
40.
Moller AB, Bibby BM, Skjerbaek AG, Jensen E, Sorensen H, Stenager E, Dalgas U: Validity and variability of the 5-repetition sit-to-stand test in patients with multiple sclerosis. Disabil Rehabil. 2012, 34: 2251-2258. 10.3109/09638288.2012.683479.CrossRefPubMed
41.
Weller IM, Thomas SG, Corey PN, Cox MH: Prediction of maximal oxygen uptake from a modified Canadian aerobic fitness test. Can J Appl Physiol. 1993, 18: 175-188. 10.1139/h93-014.CrossRefPubMed
42.
Kuspinar A, Andersen RE, Teng SY, Asano M, Mayo NE: Predicting exercise capacity through submaximal fitness tests in persons with multiple sclerosis. Arch Phys Med Rehabil. 2010, 91: 1410-1417. 10.1016/j.apmr.2010.06.005.CrossRefPubMed
43.
Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983, 67: 361-370. 10.1111/j.1600-0447.1983.tb09716.x.CrossRefPubMed
44.
Honarmand K, Feinstein A: Validation of the hospital anxiety and depression scale for use with multiple sclerosis patients. Mult Scler. 2009, 15: 1518-1524. 10.1177/1352458509347150.CrossRefPubMed
45.
Smith A: Symbol Digits Modalities Test. Los Angeles: Western Psychological Services; 1982.
46.
Benedict RH, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N, Weinstock-Guttman B: Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006, 12: 549-558. 10.1017/S1355617706060723.CrossRefPubMed
47.
Godin G, Shephard RJ: A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985, 10: 141-146.PubMed
48.
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P: International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003, 35: 1381-1395. 10.1249/01.MSS.0000078924.61453.FB.CrossRefPubMed
49.
Motl RW, McAuley E, Snook EM, Scott JA: Validity of physical activity measures in ambulatory individuals with multiple sclerosis. Disabil Rehabil. 2006, 28: 1151-1156. 10.1080/09638280600551476.CrossRefPubMed
50.
Snook EM, Motl RW, Gliottoni RC: The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis. Clin Rehabil. 2009, 2: 248-258. 10.1177/0269215508101757.CrossRef
51.
Gosney JL, Scott JA, Snook EM, Motl RW: Physical activity and multiple sclerosis: validity of self-report and objective measures. Fam Community Health. 2007, 30: 144-150. 10.1097/01.FCH.0000264411.20766.0c.CrossRefPubMed
52.
Coote S, O’Dwyer C: Comparative validity of accelerometer-based measures of physical activity for people with multiple sclerosis. Arch Phys Med Rehabil. 2012, 93: 2022-2028. 10.1016/j.apmr.2012.05.010.CrossRefPubMed
53.
Borg G: Borg’s perceived exertion and pain scales. 1998, Champaign IL, US
54.
Rovniak LS, Anderson ES, Winett RA, Stephens RS: Social cognitive determinants of physical activity in young adults: a prospective structural equation analysis. Ann Behav Med. 2002, 24: 149-156. 10.1207/S15324796ABM2402_12.CrossRefPubMed
55.
McAuley E, Motl RW, White SM, Wojcicki TR: Validation of the multidimensional outcome expectations for exercise scale in ambulatory, symptom-free persons with multiple sclerosis. Arch Phys Med Rehabil. 2010, 91: 100-105. 10.1016/j.apmr.2009.09.011.CrossRefPubMed
56.
Cutrona CE, Russell DW: The provisions of social relationships and adaptation to stress. Adv Pers Relatsh. 1987, 1: 36-37.
57.
Plow MA, Resnik L, Allen SM: Exploring physical activity behaviour of persons with multiple sclerosis: a qualitative pilot study. Disabil Rehabil. 2009, 31: 1652-1665. 10.1080/09638280902738375.CrossRefPubMedPubMedCentral
58.
Plow M, Finlayson M, Motl RW, Bethoux F: Randomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol. BMC Neurol. 2012, 12: 122-10.1186/1471-2377-12-122.CrossRefPubMedPubMedCentral
59.
Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A: The multiple sclerosis impact scale (MSIS-29): a new patient-based outcome measure. Brain. 2001, 124: 962-973. 10.1093/brain/124.5.962.CrossRefPubMed
60.
Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Thompson AJ: Multiple sclerosis impact scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry. 2002, 73: 701-704. 10.1136/jnnp.73.6.701.CrossRefPubMedPubMedCentral
61.
Rietberg MB, Van Wegen EE, Kwakkel G: Measuring fatigue in patients with multiple sclerosis: reproducibility, responsiveness and concurrent validity of three Dutch self-report questionnaires. Disabil Rehabil. 2010, 32: 1870-1876. 10.3109/09638281003734458.CrossRefPubMed
62.
Amtmann D, Bamer AM, Noonan V, Lang N, Kim J, Cook KF: Comparison of the psychometric properties of two fatigue scales in multiple sclerosis. Rehabil Psychol. 2012, 57: 159-166. 10.1037/a0027890.CrossRefPubMedPubMedCentral
63.
Glenton C, Lewin S, Scheel IB: Still too little qualitative research to shed light on results from reviews of effectiveness trials: a case study of a Cochrane review on the use of lay health workers. Implement Sci. 2011, 27: 53-10.1186/1748-5908-6-53.CrossRef
64.
Sandelowski M: Whatever happened to qualitative description?. Res Nurs Health. 2000, 23: 334-340. 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G.CrossRefPubMed
65.
Neergaard MA, Olesen F, Andersen RS, Sondergaard J: Qualitative description - the poor cousin of health research?. BMC Med Res Methodol. 2009, 9: 52-10.1186/1471-2288-9-52.CrossRefPubMedPubMedCentral
66.
Coote S, Garrett M, Hogan N, Larkin A, Saunders J: Getting the balance right: a randomised controlled trial of physiotherapy and Exercise Interventions for ambulatory people with multiple sclerosis. BMC Neurol. 2009, 9: 34-10.1186/1471-2377-9-34.CrossRefPubMedPubMedCentral
Metadata
Title
A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol
Authors
Susan Coote
Stephen Gallagher
Rachel Msetfi
Aidan Larkin
John Newell
Robert W Motl
Sara Hayes
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2014
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-014-0241-9

Other articles of this Issue 1/2014

BMC Neurology 1/2014 Go to the issue

Study protocol

The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results

Case report

A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann’s syndrome

Case report

Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature

Research article

Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension

Research article

Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hocanalysis of the RECOVER study

Study protocol

GAME (Goals - Activity - Motor Enrichment): protocol of a single blind randomised controlled trial of motor training, parent education and environmental enrichment for infants at high risk of cerebral palsy